NFKB1 and chronic kidney disease: Inhibition of NF-κB signaling through feeding of a chemical inhibitor, pyrrolidine dithiocarbamate, has been shown to decrease inflammation and CKD development in various animal models, including: type 1 diabetes41, adenine overload42, and 5/6 nephrectomy43.